🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Blue Earth Diagnostics is excited to connect with industry leaders and #Urology experts at the historic @SeaboardMed Conference in Kitty Hawk, June 19-22. Stop by our booth & chat about how #MolecularImaging is advancing diagnostics for those with #ProstateCancer. #HealthcareInnovation

From June 21-24, we'll be at the SNMMI Annual Meeting—where groundbreaking research meets #ClinicalInnovation. We look forward to connecting with leaders in #NuclearMedicine & #MolecularImaging and exploring how these advancements are transforming #PatientCare. #SNMMI2025

Meet us in Charleston on June 14 at the The Lowcountry Open, a unique charity fishing event supporting the fight against #ProstateCancer. As a proud ZERO Prostate Cancer partner, we’re honored to join the cause. Visit our booth to learn how we support #PrecisionMedicine. ⁠ #BlueEarthDx

Heading to Boston for the LUGPA LUGPA Regional Meeting on June 20–21? Let’s connect! Blue Earth Diagnostics will be there to share how our innovations in diagnostic imaging support urologists and the future of precision medicine. #BlueEarthDx #LUGPA2024 #Urology

In modern #Urology, accurate #ProstateCancer detection is crucial. #PETImaging offers precise images, allowing you to detect cancer earlier, stage it more accurately, and create personalized treatment plans. Have you implemented PET in your practice?

We're getting ready for the American Brachytherapy Society Annual Meeting in Nashville, June 18-21. Our team is excited to engage with #Urologists, healthcare leaders, and #MolecularImaging experts to share how our diagnostics support precision medicine. #ProstateCancer #HealthcareInnovation

We're counting down to the @SeaboardMed Conference in Kitty Hawk, June 19-22. Our team looks forward to great conversations on #MolecularImaging and its role in precision medicine for #ProstateCancer. #HealthcareInnovation

We’re committed to advancing access to molecular imaging in prostate cancer care, and we’d like to hear from you. What’s the biggest barrier to using molecular imaging in your practice today? ➡️ Limited access or availability ➡️ Insurance or reimbursement concerns ➡️ Clinical

Coming soon: @BlueEarthDX is excited to present new data at #SNMMI2025. Our accepted posters will highlight continued innovation in PET imaging and radiopharmaceutical development. Watch for our full press release with details. Explore our past informational posters here:

We are looking forward to the seven abstracts that will be presented at SNMMI this year featuring Blue Earth Diagnostics products. We are proud to be one of the industry leaders in the PET diagnostics space for #ProstateCancer and look forward to seeing you at SNMMI this

We're excited to return to SNMMI for their Annual Meeting in New Orleans, June 21-24. It's always an honor to be a part of this event, connecting with experts in #NuclearMedicine # MolecularImaging. Be sure to stop by our booth! #PatientCare #SNMMI2025

Join Blue Earth Diagnostics for lunch at the #SNMMI24 Satellite Symposia WHEN: Sunday, June 22, at 11:15am WHERE: SNMMI Meeting in New Orleans WHAT: POSLUMA® (flotufolastat F 18) Injection Case Study Review and Commercial Update During this session, physicians will review and discuss

We're excited to be at this year's SNMMI Annual Meeting in New Orleans! Stop by booth #1513 to discover the latest in #NuclearMedicine and say hello to our team.

It's a wonderful day to be at SNMMI! We are excited to be here on day 3 of #SNMMI. Stop by booth #1513 to discuss the latest news in PET diagnostic imaging. Learn more about the full SNMMI program at bit.ly/4ebNwQy

We had a great time at SNMMI this year in New Orleans, LA. Thank you to everyone who stopped by booth and connected with us. We will see you next year in Los Angeles, CA!

Blue Earth Diagnostics is looking for talented individuals to join our team & help improve clinical choices for cancer patients. Are you a General Counsel, Medical Science Liaison, Principal Financial Analyst, or Strategic Accounts Manager? Apply today. #JoinOurTeam

Thanks to everyone who joined us at #SNMMI25 for our Satellite Symposia. It was a privilege to present the latest POSLUMA® (flotufolastat F 18) Injection case study review. Explore the case study: bit.ly/3Tb4zIZ #MolecularImaging #DiagnosticImaging

Did you know #MolecularImaging is now recognized as a standard tool for staging high-risk #ProstateCancer? PSMA PET is included in NCCN, EAU, and AUA guidelines for initial staging. Understanding where it fits in clinical practice can change the course of treatment. #UroTwitter

Thank you to everyone who joined us at the @LowCountryOpen in Charleston. We're proud to support this unique event benefitting @ZeroCancer and the shared mission to end #ProstateCancer. #BlueEarthDx #MolecularImaging #PrecisionMedicine

Heading to the Texas Urological Society Annual Meeting in San Antonio next week? Stop by our booth to discuss how #PrecisionMedicine tools support patient diagnostics. Let’s connect at #TUS2025 and explore the future of personalized care and #HealthcareInnovation.